相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Mortality Risk of Proton Pump Inhibitors in 1.9 Million US Seniors: An Extended Cox Survival Analysis
Seo H. Baik et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
No Associations Between Regular Use of Proton Pump Inhibitors and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort of 0.44 Million Participants
Qiangsheng He et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study
Xinchen Wang et al.
BRITISH JOURNAL OF CANCER (2021)
The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study
Rianne M. Douwes et al.
PLOS MEDICINE (2020)
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
Paul Moayyedi et al.
GASTROENTEROLOGY (2019)
Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study
Yan Xie et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Proton pump inhibitors, adverse events and increased risk of mortality
Aitor Lanas-Gimeno et al.
EXPERT OPINION ON DRUG SAFETY (2019)
Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis
Silvia Nardelli et al.
HEPATOLOGY (2019)
Treatment with proton pump inhibitors is associated with increased mortality in patients with pyogenic liver abscess
D. Bettinger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication
Long H. Nguyen et al.
GASTROENTEROLOGY (2018)
Proton pump inhibitor use and cancer mortality
Siri A. Tvingsholm et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults
Jan Zirk-Sadowski et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
Effect of Proton Pump Inhibitors on Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis
Tsung-Hsing Hung et al.
ANNALS OF HEPATOLOGY (2018)
Complications of Proton Pump Inhibitor Therapy
Michael F. Vaezi et al.
GASTROENTEROLOGY (2017)
Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease
Derk C. F. Klatte et al.
GASTROENTEROLOGY (2017)
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
Daniel E. Freedberg et al.
GASTROENTEROLOGY (2017)
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury
Yan Xie et al.
KIDNEY INTERNATIONAL (2017)
Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans
Yan Xie et al.
BMJ OPEN (2017)
Proton Pump Inhibitors in cancer patients: How useful they are? A review of the most common indications for their use
Gianmauro Numico et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
The lag-time approach improved drug-outcome association estimates in presence of protopathic bias
Andrea Arfe et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD
Yan Xie et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Benjamin Lazarus et al.
JAMA INTERNAL MEDICINE (2016)
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
Elizabeth D. Kantor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Active-comparator design and new-user design in observational studies
Kazuki Yoshida et al.
NATURE REVIEWS RHEUMATOLOGY (2015)
Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis
G. Dultz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
Nigam H. Shah et al.
PLOS ONE (2015)
Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis
Jee Hye Kwon et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use
Mei-Ling Blank et al.
KIDNEY INTERNATIONAL (2014)
Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study
Brittany M. Charlton et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Indications and safety of proton pump inhibitor drug use in patients with cancer
George Triadafilopoulos et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Proton Pump Inhibitors and Risk of 1-Year Mortality and Rehospitalization in Older Patients Discharged From Acute Care Hospitals
Marcello Maggio et al.
JAMA INTERNAL MEDICINE (2013)
Alternative Dietary Indices Both Strongly Predict Risk of Chronic Disease
Stephanie E. Chiuve et al.
JOURNAL OF NUTRITION (2012)
Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use A Nationwide Cohort Study
Mette Charlot et al.
ANNALS OF INTERNAL MEDICINE (2010)
Application of lag-time into exposure definitions to control for protopathic bias
H. Tamim et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
分享论文
